CD4 tests is strongly recommended as the preferred method to identify advanced HIV disease among people living with HIV, said ...

CD4 tests is strongly recommended as the preferred method to identify advanced HIV disease among people living with HIV, said ...

Checking CD4 helper T cell levels up to 4 times a year has been a mainstay of HIV/AIDS monitoring, but the value of the test has diminished as the ability to directly detect viral RNA has improved and ...

A new point-of-care test to measure CD4 T-cells, the prime indicator of HIV disease progression, can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve ...

A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found ...

Research in Mozambique has found that the introduction of rapid point-of-care CD4 testing* almost halved the number of patients who dropped out before starting antiretroviral therapy (ART), and nearly ...

SEATTLE — Patients who initiate ART without pretherapy CD4 monitoring experience a higher risk for early mortality than those who are tested, study data presented at CROI suggest. “We think that it’s ...

Viral load tests which essentially count the number of HIV particles in a patient s circulation are routinely used to assess the status of an HIV patient. This allows them to recommend optimal modes ...

Global AIDS experts say “in these economic times” they’re looking for ways to get more HIV positive people into treatment using the money and resources they already have. Local researchers who say ...

California diagnostic maker Zyomyx pulled in $7.5 million from World Health Organization-hosted UNITAID to support commercialization of its point-of-care HIV/AIDS test in the developing world. Zyomyx, ...

CD4 tests are strongly recommended as the preferred method to identify advanced HIV disease among people living with HIV, the ...

Routine use of point-of-care CD4 testing at the time of HIV diagnosis would be cost effective in countries where health care and other resources are severely limited, experts say. A new point-of-care ...